Latest filing published 22 Sept 2026 for Veracyte, INC., €140k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
John Leite is a declared insider of Veracyte, Inc. (senior executive), with filings sourced from SEC (Form 4). The record holds 23 filings, for trades running from 2 September 2023 to 21 September 2026.
The open-market record consists of 7 sales worth €740k, with no purchase. Other entries cover 16 share grants. 2026 to date brings no purchases and 2 sales.
On 22 September 2026 came the latest disclosure, an open-market sale for €140k in Veracyte, Inc. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
23 of 23 declarations